Polymorphism biomarker for predicting prognosis in lung cancer patients and the method for predicting prognosis using the same

摘要

The present invention relates to a polymorphic marker for the prognosis of lung cancer patients and a method of predicting the prognosis of lung cancer using the same. More particularly, the present invention relates to polymorphisms of 8 polynucleotides (CD3EAP, TNFRSF10B, AKT1, C3, HOMER2, GNB2L1, CD3D and ADAMTSL3) To a biomarker for diagnosing the prognosis of lung cancer patients, and to a prognostic method of lung cancer prognosis using the same. The present invention provides a marker for lung cancer prognosis diagnosis that comprehensively diagnoses the prognosis after lung cancer surgery based on the polymorphisms of CD3EAP, TNFRSF10B, AKT1, C3, HOMER2, GNB2L1, CD3D or ADAMTSL3, It will be useful as a medical tool.